Flagship Pioneering as of March 31, 2023
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 11 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 76.9 | $2.0B | 13M | 153.58 | |
| Omega Therapeutics (OMGAQ) | 6.8 | $176M | 29M | 6.03 | |
| Seres Therapeutics | 5.1 | $131M | 23M | 5.67 | |
| Sana Biotechnology (SANA) | 4.4 | $112M | 34M | 3.27 | |
| Foghorn Therapeutics (FHTX) | 3.1 | $79M | 13M | 6.20 | |
| Denali Therapeutics (DNLI) | 2.3 | $60M | 2.6M | 23.04 | |
| Axcella Health Inc equity | 0.5 | $14M | 29M | 0.48 | |
| Sigilon Therapeutics | 0.4 | $9.6M | 10M | 0.93 | |
| Evelo Biosciences | 0.4 | $9.1M | 50M | 0.18 | |
| Syros Pharmaceuticals (SYRS) | 0.1 | $2.7M | 994k | 2.67 | |
| Codiak Biosciences | 0.0 | $618k | 3.5M | 0.17 |
